The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EMMA 2016 | Overview and rationale for practical workshops at the 2016 European Multiple Myeloma Academy (EMMA)
Jesús San Miguel, MD, PhD of University Clinic of Navarra, Pamplona, Spain summarizes the topics of the workshops held at the 2016 European Multiple Myeloma Academy (EMMA) in Madrid, Spain. Prof. San Miguel, co-chair of the meeting, explains that four areas of relevance to clinical practice were covered; the new diagnostic response criteria, early diagnosis and treatment, monoclonal gammopathy of undetermined significance (MGUS), and complications.
This programme has been supported by Celgene and Amgen through an unrestricted educational grant to the Video Journal of Hematological Oncology.
